What is LCTX stock price today?

Visit our real-time dashboard for the current LCTX stock price and live market data.

Is LCTX stock going up or down today?

LCTX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LCTX stock now?

The decision to buy LCTX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LCTX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LCTX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LCTX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LCTX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LCTX's P/E ratio?

P/E ratio data for LCTX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LCTX's market cap?

LCTX (Lineage Cell Therapeutics Inc) has a market capitalization of $0.21 billion, making it a small-cap stock.

What is LCTX's price to book ratio?

Price-to-book ratio for LCTX is available on our dashboard along with other valuation metrics.

Does LCTX pay dividends?

LCTX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LCTX's dividend yield?

LCTX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LCTX stock a good long-term investment?

LCTX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LCTX's revenue growth rate?

Revenue growth data for LCTX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for LCTX are available on our dashboard with complete income statement analysis.

What are the risks of investing in LCTX?

Key risks for LCTX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LCTX compare to its competitors?

Compare LCTX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LCTX's performance and positioning.

What is LCTX's stock price target for 2026?

Visit our prediction page for AI-powered price targets for LCTX with bull, base, and bear case scenarios.

What do analysts say about LCTX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LCTX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LCTX's next earnings report?

LCTX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LCTX - Lineage Cell Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc (LCTX) common stock

Price Chart

Loading chart...

LCTX Key Statistics

Market Cap

$213.56M

How LCTX Compares to Peers

LCTX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LCTX(This stock)	$213.56M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 4:08 AM EDT

Ready to invest in LCTX?

Commission-free trading available. Affiliate links.

LCTX Lician Score

10% confidence

6.0/10

Good

LCTX has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates LCTXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

LCTX Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for LCTX

Dashboard

Enter a ticker to analyze